Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 61 referenced papers

Top Authors

John W. Foreman
University of Pennsylvania
Elena Levtchenko
Emma Kinderziekenhuis
Mohamed A. Elmonem
Cairo University
Ali Kırık
Balıkesir University
Ömer Toprak
Balıkesir University
Francesco Emma
Bambino Gesù Children's Hospital
Dieter Haffner
Medizinische Hochschule Hannover
Koenraad Veys
Universitair Ziekenhuis Leuven
Craig B. Langman
Northwestern University

Top Institutions

Ranked by publications Top 10 institutions
03

Balıkesir University

Balıkesir, Türkiye

1 paper
07

Emma Kinderziekenhuis

Amsterdam, The Netherlands

48 papers

References

References (61)
  1. 1

    Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study.

    Liang H, Baudouin C, Tahiri Joutei Hassani R, et al.

    Investigative ophthalmology & visual science 2015; (56(5)):3218-25 doi:10.1167/iovs.15-16499.

    PMID: 26024106
  2. 2

    A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.

    Yamaguchi S, Maruyama T, Wakino S, et al.

    BMC nephrology 2015; (16()):187 doi:10.1186/s12882-015-0184-4.

    PMID: 26554665
  3. 3

    Lysosomal cystine accumulation promotes mitochondrial depolarization and induction of redox-sensitive genes in human kidney proximal tubular cells.

    Sumayao R, McEvoy B, Newsholme P, McMorrow T

    The Journal of physiology 2016; (594(12)):3353-70 doi:10.1113/JP271858.

    PMID: 26915455
  4. 4

    Cystinosis: a review.

    Elmonem MA, Veys KR, Soliman NA, et al.

    Orphanet journal of rare diseases 2016; (11()):47 doi:10.1186/s13023-016-0426-y.

    PMID: 27102039
  5. 5

    Infantile nephropathic cystinosis with incomplete fanconi syndrome, hypothyroidism, hydro-uretero-nephrosis, and megacystis.

    More V, Shanbag P

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2016; (27(3)):598-601 doi:10.4103/1319-2442.182438.

    PMID: 27215258
  6. 6

    Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis.

    Cheung WW, Cherqui S, Ding W, et al.

    Journal of cachexia, sarcopenia and muscle 2016; (7(2)):152-64 doi:10.1002/jcsm.12056.

    PMID: 27493869
  7. 7

    Bartter syndrome associated with nephropathic cystinosis.

    Osman NM, Sanosi AA

    Sudanese journal of paediatrics 2016; (16(2)):93-98.

    PMID: 28096565
  8. 8

    Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction.

    Elmonem MA, Khalil R, Khodaparast L, et al.

    Scientific reports 2017; (7()):42583 doi:10.1038/srep42583.

    PMID: 28198397
  9. 9

    Ocular Complications of Infantile Nephropathic Cystinosis.

    Bishop R

    The Journal of pediatrics 2017; (183S()):S19-S21 doi:10.1016/j.jpeds.2016.12.055.

    PMID: 28343471
  10. 10

    Bone Complications of Cystinosis.

    Langman CB

    The Journal of pediatrics 2017; (183S()):S2-S4 doi:10.1016/j.jpeds.2016.12.052.

    PMID: 28343472
  11. 11

    Diagnosis of Nephropathic Cystinosis in a Child During Routine Eye Exam.

    Ecel M, Sarı A, Delibaş A

    Turkish journal of ophthalmology 2017; (47(5)):292-295 doi:10.4274/tjo.69922.

    PMID: 29109899
  12. 12

    AJKD Atlas of Renal Pathology: Cystinosis.

    Lusco MA, Najafian B, Alpers CE, Fogo AB

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2017; (70(6)):e23-e24 doi:10.1053/j.ajkd.2017.10.002.

    PMID: 29169518
  13. 13

    Effects of long-term cysteamine treatment in patients with cystinosis.

    Ariceta G, Giordano V, Santos F

    Pediatric nephrology (Berlin, Germany) 2019; (34(4)):571-578 doi:10.1007/s00467-017-3856-4.

    PMID: 29260317
  14. 14

    Nephropathic Cystinosis Mimicking Bartter Syndrome: a Novel Mutation.

    Bastug F, Nalcacioglu H, Ozaltin F, et al.

    Iranian journal of kidney diseases 2018; (12(1)):61-63.

    PMID: 29421779
  15. 15

    Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.

    Bertholet-Thomas A, Claramunt-Taberner D, Gaillard S, et al.

    Pediatric nephrology (Berlin, Germany) 2018; (33(7)):1165-1172 doi:10.1007/s00467-018-3902-x.

    PMID: 29435659
  16. 16

    Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease.

    Bäumner S, Weber LT

    Frontiers in pediatrics 2018; (6()):58 doi:10.3389/fped.2018.00058.

    PMID: 29594088
  17. 17

    Hypophosphatemia in a Malnourished Child: When Renal Fanconi Syndrome Does Not Stand for Refeeding Syndrome.

    Runde J, Rivera-Rivera E, Pompeii-Wolfe C, et al.

    JPEN. Journal of parenteral and enteral nutrition 2019; (43(1)):166-169 doi:10.1002/jpen.1177.

    PMID: 29746006
  18. 18

    Skeletal Consequences of Nephropathic Cystinosis.

    Florenzano P, Ferreira C, Nesterova G, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(10)):1870-1880 doi:10.1002/jbmr.3522.

    PMID: 29905968
  19. 19

    Atypical onset of nephropathic infantile cystinosis in a Russian patient with rare CTNS mutation.

    Anastasiya KA, Elena OG, Natalia BV, et al.

    Clinical case reports 2018; (6(9)):1871-1876 doi:10.1002/ccr3.1678.

    PMID: 30214781
  20. 20

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  21. 21

    Intrinsic Bone Defects in Cystinotic Mice.

    Battafarano G, Rossi M, Rega LR, et al.

    The American journal of pathology 2019; (189(5)):1053-1064 doi:10.1016/j.ajpath.2019.01.015.

    PMID: 30794806
  22. 22

    Renal Tubular Acidosis Presenting as Nephrogenic Diabetes Insipidus.

    Das D, Sinha R, Dey S

    Indian pediatrics 2019; (56(4)):325-327.

    PMID: 31064905
  23. 23

    Management of bone disease in cystinosis: Statement from an international conference.

    Hohenfellner K, Rauch F, Ariceta G, et al.

    Journal of inherited metabolic disease 2019; (42(5)):1019-1029 doi:10.1002/jimd.12134.

    PMID: 31177550
  24. 24

    Nephropathic cystinosis presenting with uveitis: Report of a "Can't See, Can't Pee" situation.

    Matthai SM, Jacob S, Bindra MS, et al.

    Indian journal of pathology & microbiology 2019; (62(3)):457-460 doi:10.4103/IJPM.IJPM_623_18.

    PMID: 31361240
  25. 25

    Clinical myopathy in patients with nephropathic cystinosis.

    Sadjadi R, Sullivan S, Grant N, et al.

    Muscle & nerve 2020; (61(1)):74-80 doi:10.1002/mus.26726.

    PMID: 31588568
  26. 26

    CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.

    Papizh S, Serzhanova V, Filatova A, et al.

    BMC nephrology 2019; (20(1)):400 doi:10.1186/s12882-019-1589-2.

    PMID: 31672123
  27. 27

    Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis.

    De Rasmo D, Signorile A, De Leo E, et al.

    International journal of molecular sciences 2019; (21(1)) doi:10.3390/ijms21010192.

    PMID: 31888107
  28. 28

    Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study.

    Csorba A, Maka E, Maneschg OA, et al.

    BMC ophthalmology 2020; (20(1)):73 doi:10.1186/s12886-020-01336-w.

    PMID: 32102651
  29. 29

    Nephropathic cystinosis: an update on genetic conditioning.

    Topaloglu R

    Pediatric nephrology (Berlin, Germany) 2021; (36(6)):1347-1352 doi:10.1007/s00467-020-04638-9.

    PMID: 32564281
  30. 30

    Clinical trial readiness study of distal myopathy and dysphagia in nephropathic cystinosis.

    Sadjadi R, Sullivan S, Grant N, et al.

    Muscle & nerve 2020; (62(6)):681-687 doi:10.1002/mus.27039.

    PMID: 32737993
  31. 31

    A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.

    Berends CL, Pagan L, van Esdonk MJ, et al.

    Pharmacology research & perspectives 2021; (9(2)):e00739 doi:10.1002/prp2.739.

    PMID: 33764642
  32. 32

    An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.

    Emma F, Hoff WV, Hohenfellner K, et al.

    Kidney international 2021; (100(5)):1112-1123 doi:10.1016/j.kint.2021.06.019.

    PMID: 34237326
  33. 33

    Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model.

    Goodman S, Khan M, Sharma J, et al.

    Molecular genetics and metabolism 2021; (134(4)):309-316 doi:10.1016/j.ymgme.2021.11.006.

    PMID: 34823997
  34. 34

    Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: A cross-sectional analysis of 55 patients.

    Vill K, Müller-Felber W, Landfarth T, et al.

    Journal of inherited metabolic disease 2022; (45(2)):183-191 doi:10.1002/jimd.12464.

    PMID: 34888877
  35. 35

    Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.

    Kluck R, Müller S, Jagodzinski C, et al.

    Journal of inherited metabolic disease 2022; (45(2)):192-202 doi:10.1002/jimd.12473.

    PMID: 34989402
  36. 36

    Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis.

    Vaisbich MH, Caires Ferreira J, Price H, et al.

    JIMD reports 2022; (63(1)):66-79 doi:10.1002/jmd2.12260.

    PMID: 35028272
  37. 37

    Cystinosis in Pediatric Renal Transplant Recipients: A Case-Control Study From Kuwait.

    Gheith O, Nair P, Adel M, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2022; (20(Suppl 1)):95-99 doi:10.6002/ect.MESOT2021.P40.

    PMID: 35384816
  38. 38

    Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.

    Nießl C, Boulesteix AL, Oh J, et al.

    Molecular genetics and metabolism 2022; (136(4)):268-273 doi:10.1016/j.ymgme.2022.06.010.

    PMID: 35835062
  39. 39

    Structural basis for proton coupled cystine transport by cystinosin.

    Löbel M, Salphati SP, El Omari K, et al.

    Nature communications 2022; (13(1)):4845 doi:10.1038/s41467-022-32589-2.

    PMID: 35977944
  40. 40

    Gastrointestinal Manifestations of Adult Cystinosis in Iran: A Descriptive Study.

    Nakhaie S, Sharif AS, Hosseini Shamsabadi R, et al.

    Medical journal of the Islamic Republic of Iran 2022; (36()):15 doi:10.47176/mjiri.36.15.

    PMID: 35999937
  41. 41

    The Pitfall of White Blood Cell Cystine Measurement to Diagnose Juvenile Cystinosis.

    Bondue T, Kouraich A, Berlingerio SP, et al.

    International journal of molecular sciences 2023; (24(2)) doi:10.3390/ijms24021253.

    PMID: 36674769
  42. 42

    Extrarenal complications of cystinosis.

    Topaloglu R

    Pediatric nephrology (Berlin, Germany) 2024; (39(8)):2283-2292 doi:10.1007/s00467-023-06225-0.

    PMID: 38127152
  43. 43

    The Clinical Manifestations and Disease Burden of Cystinosis in Saudi Arabia: A Single-Tertiary Center Experience.

    Algasem R, Zainy N, Alsabban E, et al.

    Cureus 2024; (16(1)):e52662 doi:10.7759/cureus.52662.

    PMID: 38380220
  44. 44

    Addressing the psychosocial aspects of transition to adult care in patients with cystinosis.

    Stabouli S, Sommer A, Kraft S, et al.

    Pediatric nephrology (Berlin, Germany) 2024; (39(10)):2861-2874 doi:10.1007/s00467-024-06345-1.

    PMID: 38517536
  45. 45

    Adherence to Cysteamine Therapy Among Patients Diagnosed with Cystinosis in Saudi Arabia: A Prospective Cohort Study.

    Algasem R, Zainy N, Alsabban E, et al.

    Pharmacy (Basel, Switzerland) 2024; (12(4)) doi:10.3390/pharmacy12040123.

    PMID: 39195852
  46. 46

    Quality of life and mental health status in caregivers of pediatric patients with nephropathic cystinosis.

    González K, Eixarch T, Nuñez L, Ariceta G

    Orphanet journal of rare diseases 2024; (19(1)):415 doi:10.1186/s13023-024-03417-1.

    PMID: 39501350
  47. 47

    Cystinosin is involved in Na+/H+ Exchanger 3 trafficking in the proximal tubular cells: new insights in the renal Fanconi syndrome in cystinosis.

    Khare V, Farre JC, Rocca C, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.02.12.637793.

    PMID: 39990449
  48. 48

    Native kidney and graft survival in a cohort of Egyptian children with nephropathic cystinosis: national referral center experience.

    Helmy R, Atia FM, Soliman NA

    Italian journal of pediatrics 2025; (51(1)):110 doi:10.1186/s13052-025-01943-7.

    PMID: 40197488
  49. 49

    Computational prediction of deleterious nonsynonymous SNPs in the CTNS gene: implications for cystinosis.

    Adda Neggaz L, Dahmani AC, Derriche I, et al.

    BMC genomic data 2025; (26(1)):35 doi:10.1186/s12863-025-01325-2.

    PMID: 40375073
  50. 50

    Pediatric cystinosis: Corneal cystine deposits and papilledema in a 4-year-old:  A case report.

    Choudhary DS, Shaheen J, Kala R, et al.

    Medicine international 2025; (5(4)):43 doi:10.3892/mi.2025.242.

    PMID: 40421228
  51. 51

    Transition from pediatric to adult nephropathic cystinosis care: the structure, challenges and lessons learned.

    Borsheim B, Vissing A, Ghossein C

    Frontiers in pediatrics 2025; (13()):1584257 doi:10.3389/fped.2025.1584257.

    PMID: 40574953
  52. 52

    JIP4 deficiency causes a lysosomal storage disease arising from impaired cystine efflux.

    Nassar LM, Shi X, Roczniak-Ferguson A, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.06.06.657909.

    PMID: 40661466
  53. 53

    Local Guidance on the Management of Nephropathic Cystinosis in the Gulf Cooperation Council (GCC) Region.

    Aleid H, AlShareef T, Kaddourah A, et al.

    Children (Basel, Switzerland) 2025; (12(8)) doi:10.3390/children12080992.

    PMID: 40868444
  54. 54

    Therapeutic strategies in cystinosis: A focus on cysteamine and beyond.

    Santoro A, Ferrara YV, De Angelis A

    Experimental and molecular pathology 2025; (144()):104995 doi:10.1016/j.yexmp.2025.104995.

    PMID: 40912033
  55. 55

    Phenotypic variability in cystinosis: Lessons from an atypical case.

    Toso D, Furlano M, Tinoco A, et al.

    Nefrologia 2025; (45(7)):501342 doi:10.1016/j.nefroe.2025.501342.

    PMID: 41005824
  56. 56

    The assessment and treatment of the musculoskeletal manifestations of cystinosis.

    Singh P, Marsh D, Sharkey M

    Frontiers in nephrology 2025; (5()):1624586 doi:10.3389/fneph.2025.1624586.

    PMID: 41079531
  57. 57

    Introducing the University of California, Irvine Corneal Cystine Crystal Score: A Novel Tool for Assessing Corneal Crystal Deposition in Cystinosis Patients.

    Rezaei K, Shahraki K, Chen L, et al.

    Scientific reports 2025; (15(1)):36262 doi:10.1038/s41598-025-20108-4.

    PMID: 41102237
  58. 58

    An Isogenic Human Myoblast Cell Model for Cystinosis Myopathy Reveals Alteration of Key Myogenic Regulatory Proteins.

    Medaer L, Mora R, Zhou Z, et al.

    Journal of cachexia, sarcopenia and muscle 2025; (16(6)):e70116 doi:10.1002/jcsm.70116.

    PMID: 41208577
  59. 59

    Shimmering Clarity: A Rare Case Report of Ocular Cystinosis.

    Angadi AM, Jakhalu K, Mushtaq I, Shah S

    Case reports in ophthalmology 2025; (16(1)):847-855 doi:10.1159/000548833.

    PMID: 41321547
  60. 60

    An Extremely Low-Birth-Weight Infant With Bone Fragility Due to Fanconi Syndrome.

    Yoshida R, Hosokawa M, Ukawa T, et al.

    Kidney medicine 2026; (8(2)):101227 doi:10.1016/j.xkme.2025.101227.

    PMID: 41623299
  61. 61

    Hematopoietic Stem-Cell Gene Therapy for Cystinosis.

    Barshop BA, Ball ED, Benador N, et al.

    The New England journal of medicine 2026; (394(8)):753-762 doi:10.1056/NEJMoa2506431.

    PMID: 41707137